AzTrials
AzTrials

InfertilityINFEXONCT04539392

Assessment of the Sexuality of the Infertile Couple

An observational study of Infertility, run by Centre Hospitalier Universitaire de Nīmes at 1 site in France.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

The study hypothesis is that infertile couples experience an impact of their sexuality impacted during the diagnostic process carried out as part of the medically assisted procreation assessment, and also by the announcement of the possible cause of the couple's infertility. Read more about this study

Who is it for?
Ages 18 to 60 yearsHealthy volunteers can take part
Conditions the study is for
Infertility
What is being tested?
Questionnaires on sexuality
How many people
80 participants
Where
1 siteFrance
Study dates
28 Jun 2022to Sep 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Study population: 80 heterosexual infertile couples (according to the WHO definition) followed at the Nîmes University Hospital in the Urology / Gynecology departments.

Who may be able to join

  • Couple in which each of the two partners has signed the consent form which is presented separately and independently of their partner.
  • The patient must be a member or beneficiary of a health insurance plan
  • Heterosexual infertile couple (according to the WHO definition) monitored at the Nîmes University Hospital in the urology / gynecology departments.
  • Adult patient (≥18 years old) and under 43 years old for women, 60 years old for men

Who cannot join

  • The subject is participating in a category 1 interventional study, or is in a period of exclusion determined by a previous study
  • One member of the couple refuses to sign the consent
  • It is impossible to give the subject informed information
  • The patient is under safeguard of justice or state guardianship
  • Patient without good level of written and spoken French

Trial locations and contacts

1 site in 1 country.

France1 site
  • CHU de Nimes

    Nîmes

Other trials in France

About this study

Official title: Assessment of the Sexuality of the Infertile Couple: Prospective Cohort Study

The study hypothesis is that infertile couples experience an impact of their sexuality impacted during the diagnostic process carried out as part of the medically assisted procreation assessment, and also by the announcement of the possible cause of the couple's infertility. It is also conceivable that a disorder of the couple's sexuality forms the origin of, or is a contributor to, infertility.

Conditions
Infertility
Being tested
Questionnaires on sexuality
Medical subject headings
Infertility

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Questionnaires on sexualityOther

    Panel of questionnaires assessing sexuality, relationship satisfaction, and body image

Study groups in NCT04539392
Study groupRoleWhat they receive
Infertile coupleNot described
Receives: Other: Questionnaires on sexuality

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Sexuality of the female of the couple

    Female sexual function index: The total score is between 2 and 36 with sexual dysfunction indicated for scores below 26.55

    Measured: 2 weeks after inclusion (start of MAP)

  2. Sexuality of the female of the couple

    Female sexual function index: The total score is between 2 and 36 with sexual dysfunction indicated for scores below 26.55

    Measured: 1 month after ovarian ponction (end of MAP)

  3. Sexuality of the male of the couple

    Male Sexual Health Questionnaire

    Measured: 2 weeks after inclusion (start of MAP)

  4. Sexuality of the male of the couple

    Male Sexual Health Questionnaire

    Measured: 1 month after ovarian ponction (end of MAP)

  5. Ejactulation of the male of the couple

    Premature Ejaculation Profile

    Measured: 2 weeks after inclusion (start of MAP)

  6. Ejactulation of the male of the couple

    Premature Ejaculation Profile

    Measured: 1 month after ovarian ponction (end of MAP)

Secondary outcomes (8)
  1. Sexuality of the female of the couple

    Female sexual function index: The total score is between 2 and 36 with sexual dysfunction indicated for scores below 26.55

    Measured: 1 month after ovarian ponction (end of MAP)

  2. Sexuality of the male of the couple

    Male Sexual Health Questionnaire

    Measured: 1 month after ovarian ponction (end of MAP)

  3. Body satisfaction and global self-perception of both members of the couple

    Questionnaire de satisfaction corporelle et de perception globale de soi (QSCPGS): total score ranges from -100 to +100.

    Measured: 2 weeks after inclusion (start of MAP)

  4. Body satisfaction and global self-perception of both members of the couple

    Questionnaire de satisfaction corporelle et de perception globale de soi (QSCPGS): total score ranges from -100 to +100.

    Measured: 1 month after ovarian ponction (end of MAP)

  5. Relationship satisfaction of both members of the couple

    Dyadic Adjustment Scale-16 Distress if score less than 92 and without distress if the score is higher than 107

    Measured: 2 weeks after inclusion (start of MAP)

  6. Relationship satisfaction of both members of the couple

    Dyadic Adjustment Scale-16 Distress if score less than 92 and without distress if the score is higher than 107

    Measured: 1 month after ovarian ponction (end of MAP)

  7. Self-esteem of both members of the couple

    Rosenberg self-esteem scale: The score is between 10 and 40. A score below 25 indicates very low self-esteem. A score between 25 and 31 indicates low self-esteem. A score between 31 and 34 indicates average self-esteem. A score between 34 and 39 indicates strong self-esteem. A score above 39 indicates very high self-esteem.

    Measured: 2 weeks after inclusion (start of MAP)

  8. Self-esteem of both members of the couple

    Rosenberg self-esteem scale: The score is between 10 and 40. A score below 25 indicates very low self-esteem. A score between 25 and 31 indicates low self-esteem. A score between 31 and 34 indicates average self-esteem. A score between 34 and 39 indicates strong self-esteem. A score above 39 indicates very high self-esteem.

    Measured: 1 month after ovarian ponction (end of MAP)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Sep 2020
  2. Study start28 Jun 2022
  3. Primary completionNov 2025 (estimated)
  4. Study completionSep 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
80 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04539392
Sponsor's protocol ID
NIMAO/2019-2/SH-01
Acronym
INFEXO
Status last verified
Nov 2025
First submitted
31 Aug 2020
Last updated
17 Nov 2025
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Infertility, run by Centre Hospitalier Universitaire de Nīmes at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 17 Nov 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Sexuality of the female of the couple (time frame: 2 weeks after inclusion (start of MAP)). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Nov 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in